SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-011395
Filing Date
2024-04-23
Accepted
2024-04-23 19:30:32
Documents
2
Period of Report
2024-04-14

Document Format Files

Seq Description Document Type Size
1 form3-04232024_110425.html 3  
1 form3-04232024_110425.xml 3 8247
2 ex24-04232024_110427.htm EX-24 5287
  Complete submission text file 0001415889-24-011395.txt   15056
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Issuer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IGM IOSCIENCES, INC. 325 E,. MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94063
Business Address
Harler Mary Beth (Reporting) CIK: 0002018699 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39045 | Film No.: 24866359